 |
|
|
|
HOME
ABOUT OPEN PRAIRIE
TEAM
ENTREPRENEURS
PORTFOLIO
|
|
Harvesting Efficient InnovationTM |
 Announcements |
|
Portfolio Update
TomoTherapy Common Stock Secondary Offering
October 18, 2007: TomoTherapy Inc., a developer of cancer treatment systems
announced the pricing of a public offering of 8,500,000 shares of its common stock at a price of $22.25 per share.
According to TomoTherapy, "the closing of the offering is scheduled to take place on October 16, 2007. The selling shareholders have granted the underwriters a 30-day option to purchase up to an additional 1,275,000 shares of common stock at the public offering price to cover over-allotments, if any."
Merrill Lynch & Co. acted as sole-bookrunning manager, and Piper Jaffray & Co., Thomas Weisel Partners LLC, Robert W. Baird & Co. Incorporated and William Blair & Company acted as co-managers for the offering.
www.TomoTherapy.com
Portfolio Update
MedVenture Named in the Business First Fastest Fifty Growing Companies
October 18, 2007: MedVenture
announced today that along with another successful year, they were third in the greater Louisville region's Business First Fastest Fifty Growing Compaines demonstrating over 200% growth in the last three years.
"Our company has been and will be built with great people working together as a team to meet our clients and patients needs." said Kevin Bramer, COO.
www.MedVenture.com
Portfolio Update
TomoTherapy Prices High
May 9, 2007: TomoTherapy Inc., a Madison, Wis.-based developer of cancer treatment systems that use on-board CT imaging and conformal radiation therapy, priced around 11.7 million common shares at $19 per share, for an IPO take of $222.3 million. It had originally planned to offer around 10.94 million shares at between $15 and $17 per share. It will trade on the Nasdaq under ticker symbol TTPY, while Merrill Lynch served as lead underwriter. The company has raised around $79 million in VC funding since 1999, from shareholders like Open Prairie Ventures (6.1%), Venture Investors, Avalon Technology, The Endeavors Group, Ascension Health Ventures and the Wisconsin Alumni Research Foundation.
News
TomoTherapy Has Filed For $201.25 Million IPO
February 12, 2007: TomoTherapy Inc., a Madison, WI based developer of the Hi-Art cancer treatment on-board CT imaging radiation therapy, today filed for a $201.25 million IPO. Their plans are to trade on Nasdaq with ticker symbol TTPY and Merrill-Lynch will be the lead underwriter. Open Prairie Ventures invested in TomoTherapy in 2001 prior to FDA clearance of the Hi-Art System.
www.TomoTherapy.com
News
Venture company sees half its firms mature
April 15, 2007: The Champaign News-Gazette recently printed an article on the success of Open Prairie Ventures.
www.news-gazette.com
Press Release
Market Research Report Re-Affirms Infoblox Leadershipin Growing DNS, DHCP and IPAM
April 9, 2007: Infoblox, Inc. today announced the recently published IDC report: "Worldwide IP Address Management 2007-2011 Forecast and Analysis" (March 2007). It sizes up the market for DNS, DHCP and IPAM solution and that Infoblox is the IPAM appliance market leader with 41 percent of the market share in 2006.
Event
February 5, 2007: The Invest Midwest Venture forum will be held in Kansas City at the Sprint-Nextel Campus on April 11, 2007
Press Release
July 19, 2006: Open Prairie Ventures announced that HarbourVest Partners, LLC became a limited partner in its Open Prairie Ventures Fund I through the purchase of the stake previously held by the Small Business Administration (SBA) under the license of the SBIC program.
|
CONTACT MEDIA RELATIONS
Open Prairie Ventures
400 East Jefferson
Effingham, Illinois 62401
T
: 217-347-1000
|
|
|
HOME |
ABOUT OPEN PRAIRIE |
TEAM |
ENTREPRENEURS |
PORTFOLIO |
NEWS |
CONTACT US |
LEGAL |
INVESTOR ACCESS
|